23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
Opioids pose a substantial threat to the construction industry. According to the National Institute ...
Read More >
Maravai LifeSciences, a portfolio company of GTCR, has announced it has acquired MockV Solutions. M...
Read More >
New York Governor Andrew Cuomo signed into law yesterday a bill which will dramatically alter the wa...
Read More >
A common provision in merger agreements is denial of the right of non-parties to the agreement to as...
Read More >
Imagine that your company has just commenced an internal compliance investigation in response to an ...
Read More >
Carbon capture technology has made great advancements in recent years and Section 45Q of the Interna...
Read More >